Literature DB >> 18564101

Subependymal giant cell astrocytoma (SEGA): Is it an astrocytoma? Morphological, immunohistochemical and ultrastructural study.

Anna M Buccoliero1, Alessandro Franchi, Francesca Castiglione, Chiara F Gheri, Federico Mussa, Flavio Giordano, Lorenzo Genitori, Gian L Taddei.   

Abstract

Subependymal giant-cell astrocytoma (SEGA) is a rare intra-ventricular low-grade tumor which frequently occurs as a manifestation of tuberous sclerosis complex. The histogenesis of SEGA is controversial and its astrocytic nature has been doubted. First studies suggested the astrocytic nature of SEGA while several recent reports demonstrate its glio-neuronal nature. In spite of this, in the recently revised WHO classification of the CNS tumors, SEGA has been still included in the group of astrocytomas. We studied nine tuberous sclerosis complex-associated SEGAs. Patients were 1-18 years old. Eight patients (89%) had a solitary lesion located in the lateral ventricle close to of the head of the caudate nucleus, the remaining patient (11%) had two tumors, one located close to the head of the left caudate nucleus and the other in the central part of the right lateral ventricle. Histologically, tumors were composed of three types of cells: spindle, gemistocytic and ganglion-like. Four tumors (44%) had a prominent vascularization and three (33%) showed an angiocentric pattern. Calcifications were observed in six cases (66%). By immunohistochemistry, the majority of the tumors were GFAP- (9; 100%), neurofilament- (8, 89%), neuron-specific enolase- (9, 100%), and synaptophysin- (8; 89%) positive. Ultrastructural studies were performed on four cases. In all four there were glial cell processes filled with intermediate filaments. In one case dense core putative neurosecretory granules were appreciable. Our results emphasize the glio-neuronal nature of SEGA. We suggest moving it into the group of mixed glio-neuronal tumors under the denomination of subependymal giant cell tumor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18564101     DOI: 10.1111/j.1440-1789.2008.00934.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  18 in total

Review 1.  Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities.

Authors:  John Glod; Gilbert J Rahme; Harpreet Kaur; Eric H Raabe; Eugene I Hwang; Mark A Israel
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

2.  Intraoperative Squash Cytologic Features of Subependymal Giant Cell Astrocytoma.

Authors:  Jitendra Nasit; Viren Vaghsiya; Srilaxmi Hiryur; Smita Patel
Journal:  J Lab Physicians       Date:  2016 Jan-Jun

Review 3.  The Unwanted Cell Migration in the Brain: Glioma Metastasis.

Authors:  Xue Tao Qi; Jiang Shan Zhan; Li Ming Xiao; Lina Li; Han Xiao Xu; Zi Bing Fu; Yan Hao Zhang; Jing Zhang; Xi Hua Jia; Guo Ge; Rui Chao Chai; Kai Gao; Albert Cheung Hoi Yu
Journal:  Neurochem Res       Date:  2017-05-06       Impact factor: 3.996

4.  Tsc1 mutant neural stem/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle.

Authors:  Jing Zhou; Gayatri Shrikhande; Jing Xu; Renée M McKay; Dennis K Burns; Jane E Johnson; Luis F Parada
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

5.  Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis Complex.

Authors:  Darcy A Krueger
Journal:  Curr Treat Options Neurol       Date:  2013-10       Impact factor: 3.598

6.  Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications.

Authors:  Magdalena Ewa Tyburczy; Katarzyna Kotulska; Piotr Pokarowski; Jakub Mieczkowski; Joanna Kucharska; Wieslawa Grajkowska; Maciej Roszkowski; Sergiusz Jozwiak; Bozena Kaminska
Journal:  Am J Pathol       Date:  2010-02-04       Impact factor: 4.307

Review 7.  Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.

Authors:  Jeffrey P MacKeigan; Darcy A Krueger
Journal:  Neuro Oncol       Date:  2015-08-19       Impact factor: 12.300

Review 8.  Subependymal giant cell astrocytoma: current concepts, management, and future directions.

Authors:  Taohui Ouyang; Na Zhang; Thomas Benjamin; Long Wang; Jiantong Jiao; Yiqing Zhao; Jian Chen
Journal:  Childs Nerv Syst       Date:  2014-02-19       Impact factor: 1.475

Review 9.  Pathological and molecular advances in pediatric low-grade astrocytoma.

Authors:  Fausto J Rodriguez; Kah Suan Lim; Daniel Bowers; Charles G Eberhart
Journal:  Annu Rev Pathol       Date:  2012-10-29       Impact factor: 23.472

Review 10.  Subependymal giant cell astrocytoma associated with tuberous sclerosis presenting with intratumoral bleeding. Case report and review of literature.

Authors:  Hugo Sterman; Andre Beer Furlan; Hamilton Matushita; Manoel Jacobsen Teixeira
Journal:  Childs Nerv Syst       Date:  2012-11-09       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.